The Enterprise Value as of December 2025 (TTM) for Percheron Therapeutics Limited (PER.AX) is -2529928.00

According to Percheron Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is -2529928.00. This represents a change of -113.14% compared to the average of 19.25M of the last 4 quarters.

Percheron Therapeutics Limited (PER.AX) Historical Enterprise Value (quarterly & annually)

How has PER.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Percheron Therapeutics Limited over the last ten years is 18.11M. The current -2529928.00 Enterprise Value has changed -1497.26% with respect to the historical average. Over the past ten years (40 quarters), PER.AX's Enterprise Value was at its highest in in the June 2024 quarter at 60.30M. The Enterprise Value was at its lowest in in the June 2022 quarter at -19005780.00.

Percheron Therapeutics Limited (PER.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Percheron Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Percheron Therapeutics Limited (PER.AX) Average Enterprise Value

How has PER.AX Enterprise Value performed in the past?

The current Enterprise Value of Percheron Therapeutics Limited (PER.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Percheron Therapeutics Limited (PER.AX) Enterprise Value vs. Peers

How is PER.AX’s Enterprise Value compared to its peers?

Percheron Therapeutics Limited’s Enterprise Value is less than Invion Limited (7.37M), less than Cann Group Limited (81.46M), less than Intelicare Holdings Limited (0), less than Bio-Gene Technology Limited (6.84M), less than Invex Therapeutics Ltd (3.64M), less than HITIQ Limited (17.35M), less than ECS Botanics Holdings Ltd (14.25M), less than Adherium Limited (10.78M), less than Memphasys Limited (14.63M), less than Vectus Biosystems Limited (5.82M),

Build a custom stock screener for Percheron Therapeutics Limited (PER.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Percheron Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Percheron Therapeutics Limited (PER.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Percheron Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.